Atrial Fibrillation and Hemodialysis – Should we Anticoagulate These Patients? Ischemic Versus Hemorrhagic Risk
AUTOR(ES)
Malan, Iara Atié
FONTE
International Journal of Cardiovascular Sciences
DATA DE PUBLICAÇÃO
2022
RESUMO
Documentos Relacionados
- Hemorrhagic Versus Ischemic Risk in Patients with Atrial Fibrillation on Hemodialysis
- How vigorously should we exercise our rheumatoid arthritis patients?
- Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation
- Should We Test for CYP2C9 Before Initiating Anticoagulant Therapy in Patients with Atrial Fibrillation?
- Should we spend less or control a greater percentage of hypertensive patients?